The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group members

Nucleic Acids Research

Volumn 41, Issue 9, 2013, Pages 4847-4859

  Verger, Alexis ^a   Baert, Jean Luc ^a   Verreman, Kathye ^b   Dewitte, Frédérique ^a   Ferreira, Elisabeth ^a   Lens, Zoé ^a   De Launoit, Yvan ^b   Villeret, Vincent ^a   Monté, Didier ^a  

^a CNRS   (France)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INTERSTITIAL COLLAGENASE; MEDIATOR COMPLEX; PROTEIN ACID; PROTEIN ERM; PROTEIN MED25; PROTEIN PTOV; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PEA3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSACTIVATION; TRANSCRIPTION INITIATION;

CELL LINE; DNA-BINDING PROTEINS; HUMANS; MEDIATOR COMPLEX; MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84877248503     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt199     Document Type: Article

References (60)

1. Hollenhorst, P.C., McIntosh, L.P. and Graves, B.J. (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu. Rev. Biochem., 80, 437-471.
2. de Launoit, Y., Baert, J.L., Chotteau-Lelievre, A., Monte, D., Coutte, L., Mauen, S., Firlej, V., Degerny, C. and Verreman, K. (2006) The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim. Biophys. Acta, 1766, 79-87.
3. Defossez, P.A., Baert, J.L., Monnot, M. and de Launoit, Y. (1997) The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60. Nucleic Acids Res., 25, 4455-4463.
4. Laget, M.P., Defossez, P.A., Albagli, O., Baert, J.L., Dewitte, F., Stehelin, D. and de Launoit, Y. (1996) Two functionally distinct domains responsible for transactivation by the Ets family member ERM. Oncogene, 12, 1325-1336.
5. Degerny, C., de Launoit, Y. and Baert, J.L. (2008) ERM transcription factor contains an inhibitory domain which functions in sumoylation-dependent manner. Biochim. Biophys. Acta, 1779, 183-194.
6. Degerny, C., Monte, D., Beaudoin, C., Jaffray, E., Portois, L., Hay, R.T., de Launoit, Y. and Baert, J.L. (2005) SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. J. Biol. Chem., 280, 24330-24338.
7. Bojovic, B.B. and Hassell, J.A. (2001) The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding. J. Biol. Chem., 276, 4509-4521.
8. Janknecht, R. (1996) Analysis of the ERK-stimulated ETS transcription factor ER81. Mol. Cell Biol., 16, 1550-1156.
9. Lens, Z., Dewitte, F., Monte, D., Baert, J.L., Bompard, C., Senechal, M., Van Lint, C., de Launoit, Y., Villeret, V. and Verger, A. (2010) Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1. Biochem. Biophys. Res. Commun., 399, 104-110.
10. Cress, W.D. and Triezenberg, S.J. (1991) Critical structural elements of the VP16 transcriptional activation domain. Science, 251, 87-90.
11. Piskacek, S., Gregor, M., Nemethova, M., Grabner, M., Kovarik, P. and Piskacek, M. (2007) Nine-amino-acid transactivation domain: establishment and prediction utilities. Genomics, 89, 756-768.
12. Malik, S. and Roeder, R.G. (2010) The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet., 11, 761-772.
13. Bourbon, H.M. (2008) Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex. Nucleic Acids Res., 36, 3993-4008.
14. Mittler, G., Stuhler, T., Santolin, L., Uhlmann, T., Kremmer, E., Lottspeich, F., Berti, L. and Meisterernst, M. (2003) A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. EMBO J., 22, 6494-6504.
15. Yang, F., DeBeaumont, R., Zhou, S. and Naar, A.M. (2004) The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc. Natl Acad. Sci. USA, 101, 2339-2344.
16. Roupelieva, M., Griffiths, S.J., Kremmer, E., Meisterernst, M., Viejo-Borbolla, A., Schulz, T. and Haas, J. (2010) Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex. J. Gen. Virol., 91, 1138-1149.
17. Yang, M., Hay, J. and Ruyechan, W.T. (2008) Varicella-zoster virus IE62 protein utilizes the human mediator complex in promoter activation. J. Virol., 82, 12154-12163.
18. Lee, H.K., Park, U.H., Kim, E.J. and Um, S.J. (2007) MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. EMBO J., 26, 3545-3557.
19. Rana, R., Surapureddi, S., Kam, W., Ferguson, S. and Goldstein, J.A. (2011) Med25 is required for RNA polymerase ii recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver. Mol. Cell Biol., 31, 466-481.
20. Nakamura, Y., Yamamoto, K., He, X., Otsuki, B., Kim, Y., Murao, H., Soeda, T., Tsumaki, N., Deng, J.M., Zhang, Z. et al. (2011) Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat. Commun., 2, 251.
21. Baert, J.L., Monte, D., Musgrove, E.A., Albagli, O., Sutherland, R.L. and de Launoit, Y. (1997) Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. Int. J. Cancer, 70, 590-597.
22. Coutte, L., Monte, D., Baert, J.L. and de Launoit, Y. (1999) Genomic organization of the human e1af gene, a member of Ets transcription factors. Gene, 240, 201-207.
23. de Launoit, Y., Audette, M., Pelczar, H., Plaza, S. and Baert, J.L. (1998) The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors. Oncogene, 16, 2065-2073.
24. Baert, J.L., Beaudoin, C., Coutte, L. and de Launoit, Y. (2002) ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain. J. Biol. Chem., 277, 1002-1012.
25. Baert, J.L., Beaudoin, C., Monte, D., Degerny, C., Mauen, S. and de Launoit, Y. (2007) The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity. Oncogene, 26, 415-424.
26. Blais, A., Monte, D., Pouliot, F. and Labrie, C. (2002) Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1. J. Biol. Chem., 277, 31679-31693.
27. Bontems, F., Verger, A., Dewitte, F., Lens, Z., Baert, J.L., Ferreira, E., Launoit, Y.D., Sizun, C., Guittet, E., Villeret, V. et al. (2011) NMR structure of the human Mediator MED25 ACID domain. J. Struct. Biol., 174, 245-251.
28. Verreman, K., Baert, J.L., Verger, A., Drobecq, H., Ferreira, E., de Launoit, Y. and Monte, D. (2011) The Coactivator Activator CoAA regulates PEA3 group member transcriptional activity. Biochem. J., 439, 469-477.
29. Quinlan, K.G., Nardini, M., Verger, A., Francescato, P., Yaswen, P., Corda, D., Bolognesi, M. and Crossley, M. (2006) Specific recognition of ZNF217 and other zinc finger proteins at a surface groove of C-terminal binding proteins. Mol. Cell Biol., 26, 8159-8172.
30. Affara, M., Dunmore, B.J., Sanders, D.A., Johnson, N., Print, C.G. and Charnock-Jones, D.S. (2011) MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms. BMC Genomics, 12, 43.
31. Milbradt, A.G., Kulkarni, M., Yi, T., Takeuchi, K., Sun, Z.J., Luna, R.E., Selenko, P., Naar, A. and Wagner, G. (2011) Structure of the VP16 transactivator target in ARC/Mediator. Nat. Struct. Biol., 18, 410-415.
32. Vojnic, E., Mourao, A., Seizl, M., Simon, B., Wenzeck, L., Lariviere, L., Baumli, S., Baumgart, K., Meisterernest, M., Sattler, M. et al. (2011) The mediator MED25 activator interaction domain: structure and cooperative binding of VP16 subdomains. Nat. Struct. Biol., 18, 404-409.
33. Ikeda, K., Stuehler, T. and Meisterernst, M. (2002) The H1 and H2 regions of the activation domain of herpes simplex virion protein 16 stimulate transcription through distinct molecular mechanisms. Genes Cells, 7, 49-58.
34. Boyer, T.G., Martin, M.E., Lees, E., Ricciardi, R.P. and Berk, A.J. (1999) Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature, 399, 276-279.
35. Yuan, C.X., Ito, M., Fondell, J.D., Fu, Z.Y. and Roeder, R.G. (1998) The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl Acad. Sci. USA, 95, 7939-7944.
36. Monte, D., Coutte, L., Baert, J.L., Angeli, I., Stehelin, D. and de Launoit, Y. (1995) Molecular characterization of the ets-related human transcription factor ER81. Oncogene, 11, 771-779.
37. Oh, S., Shin, S. and Janknecht, R. (2012) ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors. Biochim. Biophys. Acta, 1826, 1-12.
38. Qin, L., Liao, L., Redmond, A., Young, L., Yuan, Y., Chen, H., O'Malley, B.W. and Xu, J. (2008) The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol. Cell Biol., 28, 5937-5950.
39. Howe, L.R., Crawford, H.C., Subbaramaiah, K., Hassell, J.A., Dannenberg, A.J. and Brown, A.M. (2001) PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J. Biol. Chem., 276, 20108-20115.
40. Borggrefe, T. and Yue, X. (2011) Interactions between subunits of the Mediator complex with gene-specific transcription factors. Semin. Cell Dev. Biol., 22, 759-768.
41. Ito, M., Yuan, C.X., Malik, S., Gu, W., Fondell, J.D., Yamamura, S., Fu, Z.Y., Zhang, X., Qin, J. and Roeder, R.G. (1999) Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell, 3, 361-370.
42. Meyer, K.D., Lin, S.C., Bernecky, C., Gao, Y. and Taatjes, D.J. (2010) p53 activates transcription by directing structural shifts in Mediator. Nat. Struct. Mol. Biol., 17, 753-760.
43. Yang, F., Vought, B.W., Satterlee, J.S., Walker, A.K., Jim Sun, Z.Y., Watts, J.L., DeBeaumont, R., Saito, R.M., Hyberts, S.G., Yang, S. et al. (2006) An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature, 442, 700-704.
44. Yamamoto, S., Eletsky, A., Szyperski, T., Hay, J. and Ruyechan, W.T. (2009) Analysis of the varicella-zoster virus IE62 N-terminal acidic transactivating domain and its interaction with the human mediator complex. J. Virol., 83, 6300-6305.
45. Brzovic, P.S., Heikaus, C.C., Kisselev, L., Vernon, R., Herbig, E., Pacheco, D., Warfield, L., Littlefield, P., Baker, D., Klevit, R.E. et al. (2011) The acidic transcription activator gcn4 binds the mediator subunit gal11/med15 using a simple protein interface forming a fuzzy complex. Mol. Cell, 44, 942-953.
46. Mas, C., Lussier-Price, M., Soni, S., Morse, T., Arseneault, G., Di Lello, P., Lafrance-Vanasse, J., Bieker, J.J. and Omichinski, J.G. (2011) Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF). Proc. Natl Acad. Sci. USA, 108, 10484-10489.
47. Di Lello, P., Jenkins, L.M., Jones, T.N., Nguyen, B.D., Hara, T., Yamaguchi, H., Dikeakos, J.D., Appella, E., Legault, P. and Omichinski, J.G. (2006) Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol. Cell, 22, 731-740.
48. Kussie, P.H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A.J. and Pavletich, N.P. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science, 274, 948-953.
49. Humphris, E.L. and Kortemme, T. (2007) Design of multi-specificity in protein interfaces. PLoS Comput. Biol., 3, e164.
50. Walker, S., Greaves, R. and O'Hare, P. (1993) Transcriptional activation by the acidic domain of Vmw65 requires the integrity of the domain and involves additional determinants distinct from those necessary for TFIIB binding. Mol. Cell Biol., 13, 5233-5244.
51. Park, J.M., Kim, H.S., Han, S.J., Hwang, M.S., Lee, Y.C. and Kim, Y.J. (2000) In vivo requirement of activator-specific binding targets of mediator. Mol. Cell Biol., 20, 8709-8719.
52. Paoletti, A.C., Parmely, T.J., Tomomori-Sato, C., Sato, S., Zhu, D., Conaway, R.C., Conaway, J.W., Florens, L. and Washburn, M.P. (2006) Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc. Natl Acad. Sci. USA, 103, 18928-18933.
53. Sato, S., Tomomori-Sato, C., Parmely, T.J., Florens, L., Zybailov, B., Swanson, S.K., Banks, C.A., Jin, J., Cai, Y., Washburn, M.P. et al. (2004) A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol. Cell, 14, 685-691.
54. Uhlmann, T., Boeing, S., Lehmbacher, M. and Meisterernst, M. (2007) The VP16 activation domain establishes an active mediator lacking CDK8 in vivo. J. Biol. Chem., 282, 2163-2173.
55. Ge, K., Cho, Y.W., Guo, H., Hong, T.B., Guermah, M., Ito, M., Yu, H., Kalkum, M. and Roeder, R.G. (2008) Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression. Mol. Cell Biol., 28, 1081-1091.
56. van Essen, D., Engist, B., Natoli, G. and Saccani, S. (2009) Two modes of transcriptional activation at native promoters by NF-kappaB p65. PLoS Biol., 7, e73.
57. Huang, Z.Q., Li, J., Sachs, L.M., Cole, P.A. and Wong, J. (2003) A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J., 22, 2146-2155.
58. Schneikert, J., Peterziel, H., Defossez, P.A., Klocker, H., Launoit, Y. and Cato, A.C. (1996) Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J. Biol. Chem., 271, 23907-23913.
59. Chen, Y., Chen, L., Li, J.Y., Mukaida, N., Wang, Q., Yang, C., Yin, W.J., Zeng, X.H., Jin, W. and Shao, Z.M. (2011) ERbeta and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells. Cancer Biol. Ther., 11, 497-511.
60. Chen, W. and Roeder, R.G. (2011) Mediator-dependent nuclear receptor function. Semin. Cell Dev. Biol., 22, 749-758.